MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CRBU has $194,984K in assets. $53,139K in debts. $11,144K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
554.23%
Cash Ratio
39.72%
Debt to Asset Ratio
27.25%
Assets Breakdown
    • Marketable securities, short-ter...
    • Operating lease, right of use as...
    • Marketable securities, long-term
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
11,144 25,201
Marketable securities, short-term
136,115 158,747
Accounts receivable
242 71
Contract assets
860 753
Other receivables
1,828 1,956
Prepaid expenses and other current assets
5,317 5,778
Total current assets
155,506 192,506
Investments in equity securities
143 132
Marketable securities, long-term
11,953 0
Property and equipment, net
7,598 8,179
Operating lease, right of use assets
16,004 16,461
Other assets
3,780 3,625
Total assets
194,984 220,903
Accounts payable
3,804 3,243
Accrued expenses and other current liabilities
19,350 20,528
Operating lease liabilities, current
2,687 2,287
Deferred revenue (1,865 and 2,487 from related party as of september30, 2025, and december31, 2024, respectively)
2,217 2,829
Total current liabilities
28,058 28,887
Deferred revenue, net of current portion (0 and 1,243 from related party as of september30, 2025, and december31, 2024, respectively)
1,756 1,772
Mskcc success payments liability
0 0
Operating lease liabilities, non-current
22,777 23,564
Deferred tax liabilities
548 548
Total liabilities
53,139 54,771
Common stock, par value 0.0001 per share, 300,000,000 shares authorized as of september30, 2025, and december31, 2024 93,468,038 and 92,378,577 shares issued and outstanding as of september30, 2025, and december31, 2024, respectively
9 9
Additional paid-in-capital
711,770 708,562
Accumulated other comprehensive income
93 40
Accumulated deficit
-570,027 -542,479
Total stockholders equity
141,845 166,132
Total liabilities and stockholders equity
194,984 220,903
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$5,317K Other receivables$1,828K Contract assets$860K Accounts receivable$242K Marketable securities,short-term$136,115K Cash and cashequivalents$11,144K Other assets$3,780K Operating lease, right ofuse assets$16,004K Property and equipment,net$7,598K Marketable securities,long-term$11,953K Investments in equitysecurities$143K Total current assets$155,506K Total assets$194,984K Total liabilities andstockholders equity$194,984K Total stockholdersequity$141,845K Total liabilities$53,139K Accumulated deficit-$570,027K Accumulated othercomprehensive income$93K Additionalpaid-in-capital$711,770K Deferred tax liabilities$548K Operating leaseliabilities, non-current$22,777K Deferred revenue, net ofcurrent portion (0 and...$1,756K Total currentliabilities$28,058K Common stock, par value0.0001 per share,...$9K Deferred revenue (1,865and 2,487 from...$2,217K Operating leaseliabilities, current$2,687K Accrued expenses andother current...$19,350K Accounts payable$3,804K

Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences, Inc. (CRBU)